Skip to main content
    E

    Ensysce Biosciences Inc (ENSC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.42
    +0.03 (+8.06%)

    Market Cap: $8.14M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Ensysce Biosciences Inc (ENSC) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Ensysce Biosciences are Dare Bioscience (DARE), Exicure (XCUR) and Soligenix (SNGX). By market cap, Ensysce Biosciences ranks 4th of the 13 companies on this page; Dare Bioscience (DARE) is the largest at $12.93M.

    Peer Comparison

    ENSC's ROIC of -260.6% is above the peer median of -783.6%, and its revenue growth of -15.1% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Ensysce Biosciences (ENSC)$8.14MN/A1.2x-280.5%-260.6%-15.1%0.00%
    Dare Bioscience Inc (DARE)$12.93MN/A6.4x0.0%N/A499.6%0.00%
    Exicure Inc (XCUR)$7.07MN/AN/A0.0%N/A928.0%0.00%
    Soligenix Inc. (SNGX)$7.50MN/AN/A0.0%N/A-100.0%0.00%
    Senti Biosciences Inc (SNTI)$5.38MN/A57.2x0.0%1039.8%-100.0%0.00%
    Enveric Biosciences Inc (ENVB)$6.78MN/A0.2x0.0%N/A-7.3%0.00%
    Skye Bioscience, Inc. Common Stock (SKYE)$4.83MN/AN/A0.0%-3685.3%0.0%0.00%
    Biovie Inc (BIVI)$12.12MN/AN/A0.0%N/A0.0%0.00%
    VistaGen Therapeutics Inc (VTGN)$8.01MN/A3.4x0.0%N/A-46.5%0.00%
    Tempest Therapeutics Inc (TPST)$7.64MN/AN/A0.0%-783.6%0.0%0.00%
    Psyence Biomedical Ltd. Common Shares (PBM)$12.00MN/AN/A0.0%N/A0.0%0.00%
    GT Biopharma Inc (GTBP)$7.67MN/AN/A0.0%N/A0.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    Peer median$7.57MN/A4.9x0.0%-783.6%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Ensysce Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Dare Bioscience Inc (DARE)
    Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States.
    DARE competitors
    Exicure Inc (XCUR)
    Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases...
    XCUR competitors
    Soligenix Inc. (SNGX)
    Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States.
    SNGX competitors
    Senti Biosciences Inc (SNTI)
    Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology...
    SNTI competitors
    Enveric Biosciences Inc (ENVB)
    Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer.
    ENVB competitors
    Skye Bioscience, Inc. Common Stock (SKYE)
    Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops...
    SKYE competitors
    Biovie Inc (BIVI)
    BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States.
    BIVI competitors
    VistaGen Therapeutics Inc (VTGN)
    VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential...
    VTGN competitors
    Tempest Therapeutics Inc (TPST)
    Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated...
    TPST competitors
    Psyence Biomedical Ltd. Common Shares (PBM)
    Psyence Biomedical Ltd. (PBM) is an innovative biotechnology company focused on harnessing the therapeutic potential of psychedelic compounds to address mental...
    GT Biopharma Inc (GTBP)
    GT Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its...
    GTBP competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors

    Frequently Asked Questions About ENSC

    Who are Ensysce Biosciences' main competitors?

    The companies most similar to Ensysce Biosciences include Dare Bioscience (DARE), Exicure (XCUR), Soligenix (SNGX), Senti Biosciences (SNTI) and Enveric Biosciences (ENVB), listed from the closest match.

    Who is Ensysce Biosciences' biggest competitor?

    Dare Bioscience (DARE) is both the largest of the similar companies at $12.93M and the closest match by business profile, size, sector and industry.

    How does ENSC stock compare with its competitors?

    ENSC's P/S is 1.2x against a peer median of 4.9x; its net margin is -280.5% against a peer median of 0.0%.

    Which of Ensysce Biosciences' competitors pays a higher dividend?

    Ensysce Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Ensysce Biosciences bigger than its competitors?

    No. Ensysce Biosciences is 4th by market cap among the 13 companies on this page; the largest is Dare Bioscience (DARE) at $12.93M.